臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"kao j h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 611-635 / 1534 (共62頁)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-07-03T03:33:21Z	High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy	Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:20Z	Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan	Liu C.-H.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:20Z	Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis	Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:17Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; PEI-JER CHEN; Kao J.-H.
臺大學術典藏	2021-07-02T03:43:04Z	Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C	Yang P.-M.; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; BOR-LUEN CHIANG; Kao J.-H.; Chen P.-J.; Chen D.-S.
臺大學術典藏	2021-07-02T03:43:02Z	Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein	Hwang L.-H.; Yang P.-M.; Lai M.-Y.; BOR-LUEN CHIANG; Kao J.-H.; Wang J.-T.; Lee S.-Y.; Chian H.-M.; Chi W.-K.; Chu Y.-D.; Chen P.-J.; Chen D.-S.
臺大學術典藏	2021-07-02T03:41:50Z	Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy	Liang C.-C.; Liu C.-H.; Lin Y.-L.; Liu C.-J.; BOR-LUEN CHIANG; Kao J.-H.
臺大學術典藏	2021-07-02T03:41:07Z	Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics	Liu W.-D.; Chang S.-Y.; Lan T.-Y.; Lin Y.-C.; Kao J.-H.; Liao C.-H.; Tsai M.-J.; Kuo P.-H.; Huang Y.-S.; Wang J.-T.; Sheng W.-H.; Hsieh S.-C.; BOR-LUEN CHIANG; Chen Y.-C.; Chang S.-C.
臺大學術典藏	2021-07-02T02:35:59Z	Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C	Liu C.-J.; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; WEI-SHIUNG YANG; Lai M.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-02T02:35:59Z	Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-α therapy	Lu J.-Y.; Chuang L.-M.; WEI-SHIUNG YANG; Tai T.-Y.; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Lee C.-Z.; Lee H.-S.
臺大學術典藏	2021-07-02T02:35:50Z	Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients	Chu C.-H.; Yang A.-M.; Kao J.-H.; Liu C.-Y.; Chang W.-H.; WEI-SHIUNG YANG
臺大學術典藏	2021-07-02T02:35:35Z	Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan	Chen C.-L.; WEI-SHIUNG YANG; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Chen C.-J.
臺大學術典藏	2021-07-02T02:35:20Z	High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments	Nien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; Kao J.-H.; WEI-SHIUNG YANG
臺大學術典藏	2021-07-02T02:35:15Z	One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosis	Nien H.-C.; Sheu J.-C.; Chi Y.-C.; Chen C.-L.; Kao J.-H.; WEI-SHIUNG YANG
臺大學術典藏	2021-07-02T02:35:12Z	Gender difference in the association between metabolic factors and hepatocellular carcinoma	Chen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; WEI-SHIUNG YANG; Kao J.-H.; Chen P.-J.; Chen H.-H.
臺大學術典藏	2021-06-25T08:10:15Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:15Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:15Z	A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients	Liu C.-H.; Liu C.-J.; CHUN-MING HONG; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-06-25T08:10:14Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:14Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.; Su T.-H.; Liu C.-J.; CHUN-MING HONG; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	Su T.-H.; Liao S.-H.; CHUN-MING HONG; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:12Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	CHUN-MING HONG; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-06-25T08:10:12Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; CHUN-MING HONG; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.

顯示項目 611-635 / 1534 (共62頁)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856565
	造訪人次 : 53375469 線上人數 : 1181 教育部委託研究計畫計畫執行:國立臺灣大學圖書館